149 related articles for article (PubMed ID: 10913588)
1. Sildenafil produces antinociception and increases morphine antinociception in the formalin test.
Mixcoatl-Zecuatl T; Aguirre-Bañuelos P; Granados-Soto V
Eur J Pharmacol; 2000 Jul; 400(1):81-7. PubMed ID: 10913588
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil increases diclofenac antinociception in the formalin test.
Asomoza-Espinosa R; Alonso-López R; Mixcoatl-Zecuatl T; Aguirre-Bañuelos P; Torres-López JE; Granados-Soto V
Eur J Pharmacol; 2001 Apr; 418(3):195-200. PubMed ID: 11343689
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
Jain NK; Patil CS; Singh A; Kulkarni SK
Pharmacology; 2003 Mar; 67(3):150-6. PubMed ID: 12571411
[TBL] [Abstract][Full Text] [Related]
4. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test.
Aguirre-Bañuelos P; Granados-Soto V
Eur J Pharmacol; 2000 Apr; 395(1):9-13. PubMed ID: 10781667
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test.
Ambriz-Tututi M; Velázquez-Zamora DA; Urquiza-Marín H; Granados-Soto V
Eur J Pharmacol; 2005 Apr; 512(2-3):121-7. PubMed ID: 15840396
[TBL] [Abstract][Full Text] [Related]
7. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
Brock SC; Tonussi CR
Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
[TBL] [Abstract][Full Text] [Related]
8. Possible activation of the NO-cyclic GMP-protein kinase G-K+ channels pathway by gabapentin on the formalin test.
Ortiz MI; Medina-Tato DA; Sarmiento-Heredia D; Palma-Martínez J; Granados-Soto V
Pharmacol Biochem Behav; 2006 Mar; 83(3):420-7. PubMed ID: 16630650
[TBL] [Abstract][Full Text] [Related]
9. Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib.
Lozano-Cuenca J; Castañeda-Hernández G; Granados-Soto V
Eur J Pharmacol; 2005 Apr; 513(1-2):81-91. PubMed ID: 15878712
[TBL] [Abstract][Full Text] [Related]
10. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
Patil CS; Singh VP; Kulkarni SK
Inflammopharmacology; 2005; 13(5-6):467-78. PubMed ID: 16280099
[TBL] [Abstract][Full Text] [Related]
11. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
Duarte ID; Ferreira SH
Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
Jain NK; Patil CS; Singh A; Kulkarni SK
Brain Res; 2001 Aug; 909(1-2):170-8. PubMed ID: 11478933
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception.
Patil CS; Jain NK; Singh A; Kulkarni SK
Pharmacology; 2003 Dec; 69(4):183-9. PubMed ID: 14624058
[TBL] [Abstract][Full Text] [Related]
14. Additive antinociception between intrathecal sildenafil and morphine in the rat formalin test.
Yoon MH; Park KD; Lee HG; Kim WM; An TH; Kim YO; Huang LJ; Hua CJ
J Korean Med Sci; 2008 Dec; 23(6):1033-8. PubMed ID: 19119449
[TBL] [Abstract][Full Text] [Related]
15. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac.
Lázaro-Ibáñez GG; Torres-López JE; Granados-Soto V
Eur J Pharmacol; 2001 Aug; 426(1-2):39-44. PubMed ID: 11525769
[TBL] [Abstract][Full Text] [Related]
16. Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway.
Tahsili-Fahadan P; Yahyavi-Firouz-Abadi N; Orandi AH; Esmaeili B; Basseda Z; Dehpour AR
Psychopharmacology (Berl); 2006 Apr; 185(2):201-7. PubMed ID: 16425058
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide.
Islas-Cadena M; Aguirre-Bañuelos P; Granados-Soto V
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):87-92. PubMed ID: 10924891
[TBL] [Abstract][Full Text] [Related]
18. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone.
Aguirre-Bañuelos P; Granados-Soto V
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):79-85. PubMed ID: 10924890
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
